Related Experiment Video
Updated: Jul 10, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Identification of atypical PML-RARA breakpoint in a patient with acute promyelocytic leukemia
Said Ismail1, Nidaa Ababneh, Abdalla Awidi
1Faculty of Medicine, University of Jordan, Amman, Jordan. sismail@ju.edu.jo
Abstract:
Acute promyelocytic leukemia (APL) of the M3 subtype is characterized by translocation t(15;17) that generates the PML-RARA fusion gene. Depending on the breakpoint position in the PML gene, 3 main fusion transcripts usually result. These breakpoints are bcr1 and bcr3 in introns 6 and 3, respectively, and bcr2 in exon 6. This report describes a rare atypical bcr2 breakpoint in a patient with morphological, cytogenetic and molecular features of APL. The presence of t(15;17) was first revealed by fluorescent in situ hybridization. Molecular analysis by reverse transcription polymerase chain reaction using primers for different PML-RARA junctions showed bands with different sizes compared with those generated from the three classical breakpoints, namely bcr1, bcr2 and bcr3. However, sequence analysis confirmed the presence of a bcr2 transcript with an atypical breakpoint within exon 6. The patient responded well to treatment and is now in complete remission. However, suggesting a favorable prognosis associated with such a rare transcript is difficult as more similar cases are needed to confirm such a conclusion. This article also stresses the importance of sequencing unusual polymerase chain reaction products to confirm their nature.
Insights
This study details a rare atypical breakpoint in Acute Promyelocytic Leukemia (APL), a subtype of M3 leukemia. Sequencing confirmed the unusual PML-RARA fusion transcript, highlighting the importance of molecular analysis in APL diagnosis.
Area of Science:
- Hematology
- Molecular Biology
- Genetics
Background:
- Acute Promyelocytic Leukemia (APL) is characterized by the t(15;17) translocation, forming the PML-RARA fusion gene.
- Three main PML-RARA fusion transcripts (bcr1, bcr2, bcr3) arise from different breakpoint locations within the PML gene.
Observation:
- A rare atypical bcr2 breakpoint within exon 6 of the PML gene was identified in a patient with APL.
- Fluorescent in situ hybridization confirmed the t(15;17) translocation.
- Reverse transcription polymerase chain reaction revealed atypical band sizes compared to classical breakpoints.
Findings:
- Sequence analysis definitively confirmed an atypical bcr2 transcript.
- The patient presented with morphological, cytogenetic, and molecular features consistent with APL.
- The patient achieved complete remission following treatment.
Implications:
- This case underscores the necessity of sequencing unusual PCR products to confirm transcript identity in APL.
- Further research with similar cases is required to determine the prognostic significance of this rare transcript.
- Accurate molecular characterization is crucial for understanding APL heterogeneity and guiding treatment.
More Related Videos
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018